Literature DB >> 25327912

Etiological diagnosis of undervirilized male/XY disorder of sex development.

Irum Atta1, Mohsina Ibrahim1, Arit Parkash1, Saira Waqar Lone1, Yasir Naqi Khan1, Jamal Raza1.   

Abstract

OBJECTIVE: To do clinical, hormonal and chromosomal analysis in undervirilized male / XY disorder of sex development and to make presumptive etiological diagnosis according to the new Disorder of Sex Development (DSD) classification system. STUDY
DESIGN: Case series. PLACE AND DURATION OF STUDY: Endocrine Unit at National Institute of Child Health, Karachi, Pakistan, from January 2007 to December 2012.
METHODOLOGY: Patients of suspected XY DSD / undervirilized male visiting endocrine clinic were enrolled in the study. Criteria suggested XY DSD include overt genital ambiguity, apparent female/male genitalia with inguinal/labial mass, apparent male genitalia with unilateral or bilateral non-palpable testes, micropenis and isolated hypospadias or with undescended testis. The older children who had delayed puberty were also evaluated with respect to DSD. As a part of evaluation of XY DSD, abdominopelvic ultrasound, karyotype, hormone measurement (testosterone, FSH, LH), FISH analysis with SRY probing, genitogram, laparoscopy, gonadal biopsy and HCG stimulation test were performed. Frequencies and percentages applied on categorical data whereas mean, median, standard deviation were calculated for continuous data.
RESULTS: A total of 187 patients met the criteria of XY DSD. Age ranged from 1 month to 15 years, 55 (29.4%) presented in infancy, 104 (55.6%) between 1 and 10 years and 28 (15%) older than 10 years. Twenty five (13.4%) were raised as female and 162 as (86.6%) male. The main complaints were ambiguous genitalia, unilateral cryptorchidism, bilateral cryptorchidism, micropenis, delayed puberty, hypospadias, female like genitalia with gonads, inguinal mass. The karyotype was 46 XY in 183 (97.9%), 46 XX in 2 (1.1%), 47 XXY in 1 (0.5%), 45 X/46 XY in 1 (0.5%) patient. HCG stimulation test showed low testosterone response in 43 (23 %), high testosterone response in 62 (33.2%), partial testosterone response in 32 (17.1%) and normal testosterone response in 50 (26.7%). Genitogram was carried out in 86 (45.98%) patients. Presumptive etiological diagnosis of androgen sensitivity syndrome/ 5-alpha reductase deficiency, testicular biosynthetic defect/ leydig cell hypoplasia, partial gonadal dysgenesis, ovotesticular DSD, XX testicular DSD, mixed gonadal dysgenesis, testicular vanishing syndrome, klinefelter syndrome, hypogonadotropic hypogonadism, isolated hypospadias and isolated micropenis was made.
CONCLUSION: Clinical, chromosomal and hormonal assessment may help in making the presumptive etiological diagnosis. Further molecular genetics analysis are needed in differentiating these abnormalities and to make a final diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25327912     DOI: 10.2014/JCPSP.714718

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  4 in total

1.  Ambiguous genitalia: An overview of 7 years experience at the Children's Hospital & Institute of Child Health, Lahore, Pakistan.

Authors:  Jaida Manzoor; Sommayya Aftab; Muhammad Yaqoob
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

Review 2.  Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide.

Authors:  Rafael Loch Batista; Berenice Bilharinho Mendonca
Journal:  Appl Clin Genet       Date:  2020-04-14

3.  Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD

Authors:  Neşe Akcan; Oya Uyguner; Firdevs Baş; Umut Altunoğlu; Güven Toksoy; Birsen Karaman; Şahin Avcı; Zehra Yavaş Abalı; Şükran Poyrazoğlu; Agharza Aghayev; Volkan Karaman; Rüveyde Bundak; Seher Başaran; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2022-02-09

4.  Disorders of sex development: a study of 194 cases.

Authors:  R Walia; M Singla; K Vaiphei; S Kumar; A Bhansali
Journal:  Endocr Connect       Date:  2018-01-31       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.